LEA46 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
LEA46 antibody; LEA4-5 antibody; At5g06760 antibody; MPH15.12 antibody; Late embryogenesis abundant protein 46 antibody; Late embryogenesis abundant protein 4-5 antibody; AtLEA4-5 antibody
Target Names
LEA46
Uniprot No.

Target Background

Function
LEA46 antibody targets a protein involved in dehydration tolerance. It plays a role in the adaptive response of vascular plants to withstand water deficit. LEA46 may exhibit chaperone-like activity under water stress conditions.
Database Links

KEGG: ath:AT5G06760

STRING: 3702.AT5G06760.1

UniGene: At.48991

Protein Families
LEA type 1 family

Q&A

What is LEA46 protein and why is it significant in plant research?

LEA46 belongs to the Late Embryogenesis Abundant (LEA) protein family in Arabidopsis thaliana (Mouse-ear cress), a model organism widely used in plant molecular biology research. LEA proteins are crucial for plant stress tolerance, particularly during dehydration, salt stress, and cold stress conditions. These proteins help maintain cellular integrity during water deficit by functioning as molecular chaperones, membrane stabilizers, and antioxidants. Research into LEA46 specifically contributes to our understanding of plant adaptation mechanisms under environmental stress, with potential applications in agricultural improvement and stress-resistant crop development. Unlike many LEA proteins that are primarily expressed during seed development, LEA46 has a distinct expression pattern warranting specific antibody-based detection methods for accurate localization studies.

What are the recommended applications for LEA46 Antibody?

LEA46 Antibody (CSB-PA779791XA01DOA) is suitable for multiple experimental applications including:

  • Western blotting - For detecting LEA46 protein expression levels in tissue extracts

  • Immunohistochemistry (IHC) - For localizing LEA46 in fixed plant tissues

  • Immunofluorescence (IF) - For subcellular localization studies

  • Immunoprecipitation (IP) - For isolating LEA46 and associated protein complexes

  • Chromatin immunoprecipitation (ChIP) - If studying transcription factor interactions

When designing experiments, researchers should consider that antibody performance varies across applications. For example, an antibody that works well in Western blotting may not perform optimally in immunohistochemistry due to differences in epitope accessibility. Testing and validation across multiple applications is essential before committing to large-scale experiments.

How should LEA46 Antibody be stored and handled to maintain optimal activity?

For optimal stability and performance of the LEA46 Antibody:

  • Store at -20°C for long-term storage (aliquot to avoid repeated freeze-thaw cycles)

  • For short-term storage (1-2 weeks), refrigerate at 2-8°C

  • Avoid more than 3-5 freeze-thaw cycles which can significantly reduce antibody activity

  • When handling, maintain sterile conditions to prevent microbial contamination

  • If diluting for experiments, use sterile buffers containing carrier proteins (0.1-1% BSA)

  • Allow antibody solutions to reach room temperature before opening containers to prevent condensation

  • Document all dilutions, storage conditions, and usage dates for reproducibility

Proper storage and handling protocols significantly impact experimental outcomes, particularly in sensitive applications like immunofluorescence where background issues can compromise data quality.

What are the recommended validation procedures for verifying LEA46 Antibody specificity?

Validating antibody specificity is crucial for generating reliable scientific data. For LEA46 Antibody, implement the following validation strategy:

  • Positive/negative controls: Use wild-type Arabidopsis tissues (positive control) alongside lea46 knockout mutants (negative control) to confirm specificity.

  • Multiple antibody approach: Compare results with at least one alternative LEA46 antibody from a different manufacturer or targeting a different epitope.

  • Peptide competition assay: Pre-incubate the antibody with excess synthetic LEA46 peptide; signal reduction confirms specificity.

  • Recombinant protein testing: Validate against purified recombinant LEA46 protein expressed in a heterologous system.

  • Cross-reactivity assessment: Test against related LEA family proteins to ensure no cross-reactivity.

  • Western blot molecular weight verification: Confirm that detected bands match the predicted molecular weight of LEA46 (approximately 46 kDa for the full-length protein).

  • Correlation with mRNA expression: Compare protein detection patterns with mRNA expression data from public databases.

These validation steps should be documented methodically, as this information is typically required by journal reviewers when evaluating immunodetection results.

How can researchers optimize immunohistochemistry protocols for LEA46 detection in plant tissues?

Optimizing immunohistochemistry for LEA46 detection in plant tissues requires attention to several critical parameters:

  • Fixation optimization: Compare multiple fixatives (4% paraformaldehyde, Carnoy's solution, glutaraldehyde) to determine which best preserves antigenicity while maintaining tissue morphology.

  • Antigen retrieval: Test multiple methods including heat-induced (citrate buffer, pH 6.0, 95°C for 10-20 minutes) and enzymatic retrieval (proteinase K digestion, 5-15 μg/mL for 5-15 minutes).

  • Blocking optimization: Use 3-5% BSA or normal serum from the same species as the secondary antibody, supplemented with 0.1-0.3% plant-specific blocking agents to reduce background.

  • Antibody titration: Test a dilution series (typically 1:100 to 1:2000) of LEA46 Antibody to determine optimal concentration balancing specific signal versus background.

  • Detection systems: Compare enzymatic detection (HRP, AP) versus fluorescence-based methods based on your research question.

  • Incubation conditions: Optimize temperature (4°C, room temperature) and duration (2 hours to overnight) for primary antibody incubation.

  • Tissue preparation: Develop appropriate sectioning techniques (paraffin, cryo, or vibratome) based on the subcellular localization information needed.

For robust experimental design, include both technical replicates (multiple sections from the same sample) and biological replicates (sections from different plants) to account for variability.

What considerations should be made when selecting controls for Western blot experiments using LEA46 Antibody?

Appropriate controls are essential for Western blot experiments with LEA46 Antibody:

Positive Controls:

  • Arabidopsis tissue with documented LEA46 expression (hydrated/dehydrated seeds, stress-treated seedlings)

  • Recombinant LEA46 protein expressed in E. coli or other expression systems

  • Transgenic plants overexpressing LEA46 with a tag (His, FLAG, etc.)

Negative Controls:

  • Arabidopsis lea46 knockout or knockdown mutants

  • Tissues where LEA46 is not expressed (based on transcriptome data)

  • Pre-immune serum control (if available)

Loading Controls:

  • Plant-specific housekeeping proteins like actin, tubulin, or GAPDH

  • Total protein stains like Ponceau S or Coomassie for normalization

Processing Controls:

  • Peptide competition assay (antibody pre-incubated with immunizing peptide)

  • Secondary antibody-only control to detect non-specific binding

  • Replicate blots with antibodies against unrelated proteins of similar abundance

When interpreting Western blot results, assess both the expected molecular weight and any potential post-translational modifications, which are common in stress-response proteins like LEAs.

Control TypeExamplesPurpose
Positive ControlsWild-type Arabidopsis under stress, Recombinant LEA46Confirm antibody functionality
Negative Controlslea46 knockout plants, Non-expressing tissuesVerify specificity
Loading ControlsActin (42 kDa), GAPDH (37 kDa)Normalize protein loading
Processing ControlsPeptide competition, Secondary-onlyDetect technical artifacts

What are common troubleshooting strategies for weak or no signal when using LEA46 Antibody?

When encountering weak or absent signals with LEA46 Antibody, systematically address these potential issues:

  • Protein extraction efficiency:

    • Use stronger extraction buffers containing appropriate detergents (0.1-1% Triton X-100, NP-40, or SDS)

    • Add protease inhibitors to prevent degradation

    • Optimize tissue grinding and homogenization procedures

    • Consider using specialized plant protein extraction kits designed for challenging tissues

  • Epitope accessibility:

    • Try multiple antigen retrieval methods if using fixed tissues

    • For Western blotting, use reducing conditions (5-10% β-mercaptoethanol or DTT)

    • Test both denaturing and native conditions for different applications

  • Antibody concentration and incubation:

    • Increase antibody concentration (reduce dilution)

    • Extend incubation time (overnight at 4°C)

    • Optimize incubation temperature (4°C vs. room temperature)

  • Detection system sensitivity:

    • Use amplification methods like tyramide signal amplification

    • Try more sensitive detection reagents (ECL Plus vs. standard ECL)

    • Increase exposure time for Western blots or imaging time for microscopy

  • Protein expression conditions:

    • LEA proteins often show condition-dependent expression; ensure samples are collected under appropriate stress conditions (drought, salt, cold)

    • Test multiple developmental stages as expression may be temporally regulated

Document all troubleshooting attempts methodically for future reference and potential publication in methodology sections.

How can non-specific binding be reduced when using LEA46 Antibody in plant tissues?

Non-specific binding is a common challenge in plant immunodetection due to complex cell wall components and secondary metabolites. Implement these approaches to minimize background:

  • Optimized blocking strategies:

    • Extend blocking time (2-3 hours at room temperature or overnight at 4°C)

    • Use plant-specific blocking reagents containing milk powder (3-5%) combined with BSA (1-3%)

    • Add 0.1-0.3% Triton X-100 to blocking buffer for better penetration

    • Include 0.1-0.5% polyvinylpyrrolidone (PVP) to bind phenolic compounds

  • Antibody purification techniques:

    • Pre-adsorb antibody against plant tissue lacking LEA46 expression

    • Consider affinity purification against the immunizing peptide

    • Use protein A/G purification to isolate IgG fraction

  • Buffer optimization:

    • Increase salt concentration in wash buffers (150-500 mM NaCl)

    • Add mild detergents (0.05-0.1% Tween-20)

    • Test different pH conditions (pH 7.0-8.0) for optimal specificity

    • Include 0.1% BSA in antibody dilution buffer

  • Sample preparation refinements:

    • Perform additional washing steps before antibody incubation

    • Pre-treat samples with hydrogen peroxide to inactivate endogenous peroxidases when using HRP-conjugated detection systems

    • Block endogenous biotin when using biotin-based detection systems

  • Protocol adjustments:

    • Reduce secondary antibody concentration

    • Use cross-adsorbed secondary antibodies

    • Increase washing duration and number of washes (5x 10 minutes)

Non-specific binding patterns often differ from specific signals in morphology and distribution; careful microscopic examination can help distinguish genuine signals from artifacts.

What methods are recommended for quantifying LEA46 protein expression levels in different plant tissues?

Accurate quantification of LEA46 protein requires appropriate methodological approaches:

  • Western blot quantification:

    • Use increasing amounts of recombinant LEA46 protein to create a standard curve

    • Employ digital imaging systems rather than film for linear detection range

    • Utilize densitometry software (ImageJ, Image Lab) with appropriate background subtraction

    • Normalize to total protein (measured by Ponceau S staining) rather than single housekeeping proteins

    • Perform technical triplicates and biological replicates (n≥3)

  • ELISA approaches:

    • Develop sandwich ELISA using two antibodies recognizing different LEA46 epitopes

    • Create standard curves using purified recombinant LEA46 protein

    • Optimize coating buffer, blocking conditions, and detection system

    • Validate linearity within the expected concentration range

  • Mass spectrometry-based quantification:

    • Utilize selected reaction monitoring (SRM) or parallel reaction monitoring (PRM)

    • Identify unique LEA46 peptides suitable for MS quantification

    • Use isotopically labeled peptide standards for absolute quantification

    • Compare results with antibody-based methods for validation

  • Image analysis for immunohistochemistry/immunofluorescence:

    • Use consistent exposure settings across all samples

    • Apply thresholding algorithms consistently

    • Measure signal intensity relative to background in defined regions of interest

    • Employ software allowing batch processing for larger datasets

When presenting quantification data, always include information about biological variability, statistical analysis methods, and technical limitations of the chosen quantification approach.

How does the performance of LEA46 Antibody compare to other detection methods for LEA proteins?

When evaluating LEA46 Antibody against alternative detection methods, consider these comparative aspects:

  • Antibody detection vs. transcript analysis:

    • LEA46 Antibody directly detects protein levels, while RT-PCR or RNA-Seq measure transcript abundance

    • Protein levels often don't perfectly correlate with transcript levels due to post-transcriptional regulation

    • Antibody detection reveals spatial information at the cellular/subcellular level that transcript analysis cannot provide

    • Combined approaches using both protein and transcript detection provide the most comprehensive analysis

  • Antibody detection vs. fluorescent protein fusions:

    • LEA46-GFP/RFP fusions provide real-time visualization in living cells

    • Fusion proteins may exhibit altered localization or function compared to native LEA46

    • Antibody detection works with native protein without modification

    • Antibody staining requires fixation, potentially introducing artifacts

  • Polyclonal vs. monoclonal antibodies:

    • Polyclonal LEA46 antibodies recognize multiple epitopes, potentially improving detection sensitivity

    • Monoclonal antibodies offer higher specificity for particular epitopes

    • Batch-to-batch variation is higher with polyclonal antibodies

    • Epitope accessibility issues may affect one antibody type more than another

  • Immunodetection vs. mass spectrometry:

    • Antibody methods typically have lower detection limits than standard MS approaches

    • MS provides unbiased detection of multiple LEA proteins simultaneously

    • Antibody detection is more accessible for most laboratories without specialized equipment

    • MS can identify post-translational modifications that antibodies may miss

What are the critical factors in experimental design when studying LEA46 protein expression during plant stress responses?

Designing rigorous experiments to study LEA46 during stress responses requires careful consideration of:

  • Stress application protocols:

    • Standardize stress intensity, duration, and application method

    • Include recovery periods to capture dynamic expression changes

    • Apply multiple stress types (drought, salt, cold) to distinguish general vs. specific responses

    • Document environmental parameters (light, temperature, humidity) that might influence results

  • Developmental staging:

    • Use precisely defined developmental stages according to established conventions

    • Consider tissue-specific responses that may vary with developmental progression

    • Include multiple time points to capture expression dynamics

  • Genetic background considerations:

    • Use appropriate wild-type controls matched to mutant lines

    • Include multiple Arabidopsis ecotypes to assess natural variation

    • Consider the influence of other genetic modifications in transgenic lines

  • Comprehensive controls:

    • Include both positive controls (known stress-responsive proteins)

    • Use negative controls (constitutively expressed proteins unaffected by stress)

    • Implement technical controls to detect potential method-specific artifacts

  • Quantification approach:

    • Establish clear criteria for quantitative analysis before beginning experiments

    • Use appropriate statistical tests based on data distribution

    • Report both biological and technical variability

  • Multi-level analysis:

    • Combine protein detection with transcript analysis

    • Correlate protein abundance with physiological parameters

    • Link molecular data to whole-plant phenotypes

Experimental FactorKey ConsiderationsCommon Pitfalls
Stress ParametersIntensity, duration, application methodInconsistent application leading to variable results
Tissue SamplingTiming, tissue type, preservation methodMixed developmental stages confounding results
Detection MethodSensitivity, specificity, dynamic rangeSignal saturation in highly expressing samples
Data AnalysisNormalization method, statistical approachInappropriate statistical tests for data distribution
ReplicationTechnical replicates, biological replicatesInsufficient replication to detect significant differences

How can researchers determine the optimal cross-linking and fixation protocols for LEA46 immunolocalization studies?

Optimizing fixation for LEA46 immunolocalization requires systematic testing of different protocols:

  • Fixative selection and optimization:

    • Compare aldehyde-based fixatives (4% paraformaldehyde, 0.5-2% glutaraldehyde)

    • Test alcohol-based fixatives (Carnoy's solution, methanol/acetone)

    • Evaluate combination protocols (paraformaldehyde followed by methanol)

    • Assess different concentrations and pH values of each fixative

  • Fixation duration and temperature:

    • Test different durations (30 minutes to overnight)

    • Compare room temperature versus 4°C fixation

    • Evaluate vacuum infiltration to improve penetration in plant tissues

  • Post-fixation processing:

    • Optimize dehydration series (ethanol gradients)

    • Test different embedding media (paraffin, plastic resins, cryo-embedding)

    • Evaluate the need for permeabilization steps (0.1-1% Triton X-100, SDS, or enzyme digestion)

  • Antigen retrieval methods:

    • Compare heat-induced epitope retrieval (microwave, pressure cooker)

    • Test different retrieval buffers (citrate pH 6.0, Tris-EDTA pH 9.0)

    • Evaluate enzymatic retrieval methods (proteinase K, trypsin)

  • Systematic comparison approach:

    • Test each condition with identical antibody dilutions and detection systems

    • Score results based on signal intensity, background levels, and morphological preservation

    • Document effects on different cellular compartments and structures

The optimal protocol will balance preservation of LEA46 antigenicity with maintenance of cellular architecture, which is particularly challenging for hydrophilic proteins like LEAs that may relocalize during dehydration steps of processing.

How should researchers interpret discrepancies between LEA46 protein detection and gene expression data?

When LEA46 protein levels don't correlate with mRNA expression, consider these interpretive frameworks:

  • Post-transcriptional regulation mechanisms:

    • Evaluate microRNA regulation of LEA46 transcript

    • Assess mRNA stability and half-life under different conditions

    • Consider RNA binding proteins that might affect translation efficiency

  • Post-translational regulation:

    • Investigate protein stability and turnover rates

    • Examine potential degradation pathways (ubiquitin-proteasome system)

    • Assess if post-translational modifications affect antibody detection

  • Technical considerations:

    • Evaluate the linear detection range of both protein and mRNA methods

    • Consider time delays between transcription and translation

    • Assess epitope accessibility or masking in protein complexes

  • Biological interpretation:

    • Protein accumulation may reflect longer-term adaptation while mRNA captures immediate responses

    • Subcellular relocalization might affect extraction efficiency without changing total protein

    • Consider cell-type specific expression that might be diluted in whole-tissue extracts

  • Integrated analysis approach:

    • Use multiple detection methods for both protein and mRNA

    • Conduct time-course experiments to capture dynamic relationships

    • Correlate with functional assays to determine physiological relevance

Discrepancies often reveal important biological regulation mechanisms rather than technical artifacts, particularly for stress-responsive proteins that are subject to complex regulatory networks.

What considerations should be made when comparing LEA46 Antibody results across different plant species?

Cross-species applications of LEA46 Antibody require careful consideration of:

  • Sequence conservation analysis:

    • Perform multiple sequence alignments of LEA46 orthologs across target species

    • Identify conservation level of the specific epitope recognized by the antibody

    • Predict potential cross-reactivity based on epitope conservation

  • Validation requirements:

    • Confirm specificity in each new species using Western blotting

    • Compare detection patterns with species-specific transcript data

    • Use knockout/knockdown mutants in model species when available

  • Protocol adjustments:

    • Optimize extraction buffers for different tissue types

    • Adjust blocking reagents to account for species-specific background

    • Consider species-specific fixation requirements for immunohistochemistry

  • Interpretive considerations:

    • Account for potential differences in protein function across species

    • Consider evolutionary distance when interpreting localization or expression patterns

    • Evaluate whether detected proteins are true orthologs or paralogs

  • Complementary approaches:

    • Supplement antibody detection with MS-based peptide identification

    • Use heterologous expression systems to confirm antibody recognition

    • Develop species-specific antibodies for critical comparisons

Cross-species applications can provide valuable evolutionary insights but require rigorous validation to ensure reliable data interpretation.

How can LEA46 protein localization data contribute to understanding its functional mechanisms during stress responses?

Interpreting localization data for functional insights requires integrating multiple lines of evidence:

  • Subcellular localization patterns:

    • Correlate LEA46 localization with cellular compartments experiencing stress damage

    • Track dynamic relocalization during stress application and recovery

    • Compare patterns across different stress types (osmotic, temperature, oxidative)

  • Co-localization studies:

    • Identify potential interaction partners through dual immunolabeling

    • Determine association with membrane systems, organelles, or macromolecular complexes

    • Correlate with markers of cellular stress (e.g., reactive oxygen species indicators)

  • Structure-function analysis:

    • Connect localization patterns to known structural domains of LEA46

    • Evaluate how post-translational modifications affect localization

    • Assess conformational changes in different cellular environments

  • Functional correlation:

    • Link localization patterns to protection of specific cellular components

    • Compare wild-type localization with mutant phenotypes

    • Assess whether ectopic expression alters localization and protective function

  • Temporal dynamics:

    • Document localization changes throughout stress progression

    • Determine the timing of LEA46 accumulation relative to stress-induced damage

    • Evaluate persistence during recovery phases

Localization data can reveal whether LEA46 functions through membrane stabilization, protein anti-aggregation, or other proposed mechanisms for LEA proteins, providing crucial insights into cellular protective strategies during environmental stress.

What emerging technologies might enhance the detection and functional analysis of LEA46 protein?

Several cutting-edge approaches show promise for advancing LEA46 research:

  • Advanced imaging technologies:

    • Super-resolution microscopy (STORM, PALM) for nanoscale localization

    • Correlative light and electron microscopy (CLEM) to connect ultrastructure with protein localization

    • Light sheet microscopy for 3D visualization in intact tissues

    • Label-free imaging techniques to observe native protein without antibody interference

  • Proximity labeling approaches:

    • BioID or APEX2 fusion proteins to identify proximal interacting partners

    • Split-BioID systems for detecting condition-specific interactions

    • In vivo crosslinking followed by mass spectrometry to capture transient interactions

  • Structural biology innovations:

    • Cryo-electron microscopy for visualizing LEA46 in different conformational states

    • Nuclear magnetic resonance (NMR) to characterize intrinsically disordered regions

    • In-cell NMR to observe structural transitions under physiological conditions

  • Single-cell technologies:

    • Single-cell proteomics to detect cell-type specific expression patterns

    • Spatial transcriptomics correlated with protein localization

    • CRISPR-based tagging for endogenous protein visualization

  • Computational approaches:

    • Molecular dynamics simulations of LEA46 interactions with cellular components

    • Machine learning algorithms for predicting functional domains and interactions

    • Integrative multi-omics analysis to place LEA46 in broader stress response networks

These emerging technologies will help resolve current limitations in understanding the molecular mechanisms of LEA46 function, particularly its condition-dependent conformational changes and interaction networks.

How should researchers integrate LEA46 Antibody data with other -omics approaches for systems-level understanding?

Effective integration of antibody-based detection with multi-omics data requires:

  • Coordinated experimental design:

    • Collect samples for different analyses from the same experimental material

    • Implement consistent stress treatments and time points across platforms

    • Include appropriate controls for each methodology

  • Multi-level data acquisition:

    • Combine LEA46 protein detection with:

      • Transcriptomics (RNA-Seq, microarray)

      • Metabolomics (primary and secondary metabolites)

      • Proteomics (global protein changes)

      • Interactomics (protein-protein interactions)

      • Phenomics (physiological and morphological responses)

  • Integrative analysis approaches:

    • Utilize network analysis to identify functional modules

    • Apply machine learning for pattern recognition across datasets

    • Develop mathematical models of stress response dynamics

    • Implement visualization tools for complex multi-dimensional data

  • Validation strategies:

    • Test model predictions with targeted experiments

    • Verify key regulatory connections with genetic approaches

    • Confirm protein-protein interactions with complementary methods

  • Data management and sharing:

    • Adhere to FAIR principles (Findable, Accessible, Interoperable, Reusable)

    • Deposit data in appropriate public repositories

    • Provide detailed metadata for experimental conditions

The integration of antibody-based protein detection with other omics approaches provides a more comprehensive understanding of LEA46's role within the broader context of plant stress adaptation networks.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.